drugset / Trial / NCT05614622

Mydriatic Drops After Combined Surgery

NCT05614622

Completed 60 enrolled Rabin Medical Center
RandomizedParallel-groupSingle-blindPrevention

Summary

The study goal is to evaluate the influence of mydriatic drops on the development of posterior synechia after combined cataract and vitrectomy surgery.

Timeline

Start
2020-11-10
Primary completion
2022-01-03
Completion
2022-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject cyclopentolate Unknown 1 % Topical

Indications

No indication recorded.